Join Now! /

SleepCogni - tech innovation to tackle insomnia

Startacus RSS

by Startacus Admin


SleepCogni is a Sheffield-based healthtech startup that's developing an innovative handheld device and SaaS platform to help provide a good night's sleep

sleepcogni logoSleep problems are common, with 36% of people in the UK struggling to get to sleep at least once a week and about 30% in the US. Women have more trouble getting to sleep, and those aged 45-55 particularly so.

With how important sleep is to mental and physical health, this isn’t a great situation to be in, and people will often turn to some kind of treatment after too many nights staring at the ceiling. From supplements to ASMR to white noise machines, there are a number of things people can turn to, but not everything works for everyone, so perhaps something with clinical approval, teste on a wide range of people, could be the best bet.

Sheffield-based healthtech startup SleepCogni is developing a unique product that directly targets the wind-down process that should come before sleep, using cognitive behavioural therapy to help your body relearn how to go to sleep.

image2-600x400.This product comes in the form of a small handheld device and a bedside platform that, together with a subscription-based app, deliver visual, auditory, and tactile biofeedback personalised to you and based on the measurement of a range of physiological and behavioural sleep measures. In this way, you fully relax and let go of thoughts and feelings keeping you awake, and slip into sleep more easily.

In November, SleepCogni announced that it had raised another £1.4 million in funding from Chasnay Capital Partners, SleepCogni’s existing investors, and Innovate UK, which brings their total funding to £3.2 million. This funding will go towards scaling the business and entering the US market over the next 12 months. Along with this, the startup has hired two new executives to bring their expertise and experience to the business: Colin Greene and Andrew Morfey, formerly of Apple and AXA, respectively.

Clinical trials have gone well, showing a marked improvement in participants’ insomnia in 7 days, compared to a placebo. Given how debilitating insomnia can be, with its significant impact on how we feel and how well we can think throughout the day, we look forward to seeing this on the market and helping people find sleep.

Subscribe to our newsletter

If you would like to receive our startup themed newsletter, full of the latest startup opportunities, events, news, stories, tips and advice, then sign up here.
Startacus RSS
Business DealsSubmit Your Startup
Win TicketsNetwork and Collaborate
Our Latest Features

Published on: 17th November 2021

If you would like to enable commenting via your Startacus account, please enable Disqus functionality in your Account Settings.

Create an Idea!View Other Ideas, Projects or Startups
Why not Sign Up?
Create Projects
Edit Projects
Self Interviews
Self Starter of the Year
Product Giveaways
Subscribe to our Newsletter
Check us out at our Google+ page!